MedTrace Logo

Clinical and Biomarker Study of the Efficacy of Extracorporeal Photopheresis in Graft-versus-host Disease

NCT03124056 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2017-04-21

No results posted yet for this study

Summary

The aims of the study:

1. To evaluate the clinical efficacy of the use of extracorporeal photopheresis in the treatment of Graft-versus-host disease under standard clinical indications as pre-defined by the participants Centers (members of the Spanish Group for Hematopoietic Transplantation).
2. To explore and identify biomarkers of clinical response to extracorporeal photopheresis treatment of acute or chronic Graft-versus-host disease after Allogeneic hematopoietic stem cell transplantation

Conditions

  • Graft-versus-host Disease

Interventions

DEVICE

Extracorporeal photopheresis

Extracorporeal photopheresis using non-open system

Sponsors & Collaborators

  • Fundación para la Investigación del Hospital Clínico de Valencia

    lead OTHER

Principal Investigators

  • Carlos Solano, MD, PhD · Hospital Clinico of Valencia, Spain

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-10
Primary Completion
2017-02-28
Completion
2017-02-28
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03124056 on ClinicalTrials.gov